154 Differential effects of organ-specific immunotherapy related adverse events (irAE) on PFS and OS benefit in lung cancer patients receiving palliative immune checkpoint inhibitor immunotherapy

Lung Cancer 2026

View at publisher

Authors: Barima Asamoah, Lam Tai Chung

DOI: 10.1016/j.lungcan.2026.109102

Cited by: 0

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Lung Cancer Treatments and Mutations Immunotherapy and Immune Responses